Preliminary Structural Study of Inactivated Yellow Fever Virus

Evgeny Pichkur1,2, V.R. Samygina1,2, A. L. Ivanova3, A. Yu. Fedotov3, А. П. Иванов3, Evgeny V. Khvatov3, Aydar A. Ishmukhametov4,5, М. Ф. Ворович4,5
1National Research Centre “Kurchatov Institute”, Moscow, Russia
2Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics”, Russian Academy of Sciences, Moscow, Russia
3Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products, #N#Russian Academy of Sciences, Moscow, Russia
4Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products, Russian Academy of Sciences, Moscow, Russia
5Sechenov First Moscow State Medical University, Moscow, Russia

Tóm tắt

Từ khóa


Tài liệu tham khảo

N. J. Barrows, R. K. Campos, K. Liao, et al., Chem. Rev. 118, 4448 (2018).

T. P. Monath, Antiviral Res. 78, 16 (2008).

K. V. Pugachev, F. Guirakhoo, D. W. Trent, and T. P. Monath, Int. J. Parasitol. 33, 567 (2003).

CDC, Yellow Fever Maps (2018, accessed on April 17, 2019. https://www.cdc.gov/yellowfever/maps/index.

C. Paules and A. S. Fauci, New Engl. J. Med. 376, 1397 (2017).

T. P. Monath, C. K. Lee, J. G. Julander, et al., Vaccine 14, 3827 (2010).

A. D. Barrett and D. E. Teuwen, Curr. Opin. Immunol. 21, 308 (2009).

M. Martin, T. F. Tsai, C. B. Cropp, et al., Lancet 358, 98 (2001).

P. F. Vasconcelos, E. J. Luna, R. Galler, et al., Lancet 358, 91 (2001).

R. C. Chan, D. J. Penney, D. Little, et al., Lancet 358, 121 (2001).

T. P. Pato, M. C. O. Souza, D. A. Mattos, et al., Vaccine 37, 3214 (2019).

D. Ruzek, Ž. T. Avšič, J. Borde, et al., Antiviral Res. 164, 23 (2019).

X. Zhang, R. Jia, H. Shen, et al., Viruses 9, 338 (2017).

M. Brecher, H. Chen, B. Liu, et al., PloS One 10, e0130062 (2015).

M. Bollati, K. Alvarez, R. Assenberg, et al., Antiviral Res. 87, 125 (2010).

F. A. Ray, K. Stiasny, M. Ch. Vaney, et al., EMBO Rep. 19, 206 (2018).

E. H. Egelman, Biophys. J. 110, 1008 (2016).

Y. Zhang, J. Corver, P. R. Chipman, et al., EMBO J. 22, 2604 (2003).

R. Stass, W. M. Ng, Y. Ch. Kim, et al., Adv. Virus Res. 105, 35 (2019).

M. Sevvana, F. Long, A. S. Miller, et al., Structure 26, 1169 (2018).

T. J. Chambers and M. S. Diamond, Adv. Virus Res. 60, 273 (2003).

L. J. Reed and H. Muench, Am. J. Epidemiol. 27, 493 (1938).

A. P. Ivanov, T. D. Klebleeva, and O. E. Ivanova, Vopr.Virusol. 65, 21 (2020).

M. Trauchessec, O. Lambert, P. Bonnafous, et al., Vaccine 37, 3580 (2019).

D. Tegunov and P. Cramer, Nat. Methods 16, 1146 (2019).

J. Zivanov, T. Nakane, B. Forsberg, et al., eLife 7, e42166 (2018).

R. C. Pereira, A. N. M. R. Silva, M. C. Souza, et al., Vaccine 33, 4261 (2015).

Sh. V. A. Coelho, S. R. L. Neris, M. P. Papa, et al., J. Virol. Methods 246, 65 (2017).

H. Toriniwa and T. Komiya, Biologicals 35, 221 (2007).

N. Mittereder, K. L. March, and B. C. Trapnell, J. Virol. 70, 7498 (1996).